Short-course therapy for community-acquired pneumonia in paediatric patients

Drugs

Volumn 65, Issue 9, 2005, Pages 1179-1192

  Qazi, Shamim ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIINFECTIVE AGENT; AZITHROMYCIN; CEFUROXIME; COTRIMOXAZOLE; PENICILLIN G; PROCAINE PENICILLIN; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; BACTERIAL INFECTION; CLINICAL TRIAL; COMMUNITY ACQUIRED PNEUMONIA; DIAGNOSTIC PROCEDURE; DOSE RESPONSE; DRUG EFFICACY; HEALTH CARE COST; HEALTH CARE SYSTEM; HOSPITALIZATION; HUMAN; IMMUNOCOMPETENCE; INFECTION RISK; MORTALITY; OUTCOMES RESEARCH; PEDIATRICS; PRACTICE GUIDELINE; RESPIRATORY TRACT INFECTION; REVIEW; RISK FACTOR;

ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; DRUG ADMINISTRATION SCHEDULE; HUMANS; INFANT; INFANT, NEWBORN; PNEUMONIA, BACTERIAL; RANDOMIZED CONTROLLED TRIALS;

EID: 22744450649     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-200565090-00001     Document Type: Review

References (102)

1. Williams BG, Gouws E, Boschi-Pinto C, et al. Estimates of world-wide distribution of child deaths from acute respiratory infections. Lancet Infect Dis 2002 Jan; 2 (1): 25-32
2. World Health Organization. The world health report 2005. Make every mother and child count. Geneva: World Health Organization, 2005: 190 [online]. Available from URL: http:// www.who.int/whr/2005/whr2005_en.pdf [Accessed 2005 Apr 21]
3. Shann F, Barker J, Poore P. Clinical signs that predict death in children with severe pneumonia. Pediatr Infect Dis J 1989; 8: 852-5
4. Qazi SA, Rehman GN, Khan MA. Standard ARI case management on antibiotic use and case fatality on ARI patients at a Children's Hospital in Pakistan. Bull World Health Organ 1996; 74: 501-7
5. Duke T, Poka H, Dale F, et al. Chloramphenicol versus benzylpenicillin and gentamicin for the treatment of severe pneumonia in children in Papua New Guinea: a randomised trial. Lancet 2002 Feb 9; 359 (9305): 474-80
6. Djelantik IGG, Gessner BD, Sutanto A, et al. Case fatality proportions and predictive factors for mortality among children hospitalized with severe pneumonia in a rural developing country setting. J Trop Pediatr 2003; 49: 327-32
7. McIntosh K. Community-acquired pneumonia in children. N Engl J Med 2002 Feb 7; 346 (6): 429-37
8. Ruuskanen O, Mertsola J. Childhood community-acquired pneumonia. Semin Respir Infect 1999; 14: 163-72
9. Korppi M. Community-acquired pneumonia in children: issues in optimizing antibacterialtreatment. Paediatr Drugs 2003; 5: 821-32
10. Korppi M, Heiskanen-Kosma T, Kleemola M. Incidence of community-acquired pneumonia in children caused by Mycoplasmapneumoniae: serological results of a prospective, population-based study in primary health care. Respirology 2004; 9: 109-14
11. Heiskanen-Kosma T, Korppi M, Laurila A, et al. Chlamydia pneumoniae is an important cause of community-acquired pneumonia in school-aged children: serological results of a prospective, population-based study. Scand J Infect Dis 1999; 31: 255-9
12. Principi N, Esposito S. Emerging role of Mycoplasma pneumoniae and Chlamydia pneumoniae in paediatric respiratory-tract infections. Lancet Infect Dis 2001; 1: 334-44
13. Ghafoor A, Nomani NK, Ishaq Z, et al. Diagnoses of acute lower respiratory tract infection in children in Rawalpindi and Islamabad, Pakistan. Rev Infect Dis 1990; 12 Suppl. 8: S907-14
14. Tupasi TE, Lucero MG, Magdangal DM, et al. Etiology of acute lower respiratory tract infection in children from Alabang, Metro Manila. Rev Infect Dis 1990; 12 Suppl. 8: S929-39
15. Mastro TD, Ghafoor A, Nomani NK, et al. Antimicrobial resis-tance of pneumococci in children with acute lower respiratory tract infection in Pakistan. Lancet 1991; 337 (8734): 156-9
16. Weinberg GA, Spitzer ED, Murray PR, et al. Antimicrobial susceptibility patterns of Haemophilus isolates from children in eleven developing nations. Bull World Health Organ 1990; 68: 179-84
17. Straus WL, Qazi SA, Kundi Z, et al. Antimicrobial resistance and clinical effectiveness of co-trimoxazole versus amoxicillin for pneumonia among children in pakistan: randomised con-trolled trial. Lancet 1998, 74
18. Berkley JA, Maitland K, Mwangi I, et al. Use of clinical syndromes to target antibiotic prescribing in seriously ill children in malaria endemic area: observational study. BMJ. Epub 2005 Mar 29
19. Baqui AH, Black RE, Arifeen SE, et al. Causes of childhood deaths in Bangladesh: results of a nationwide verbal autopsy study. Bull World Health Organ 1998; 76: 161-71
20. Bulla A, Hitze KL. Acute respiratory infections: a review. Bull World Health Organ 1978; 56: 481-98
21. World Health Organization (WHO). Technical bases for the WHO recommendations on the management of pneumonia in children at first-level health facilities. Programme for the Control of Acute Respiratory Infections. Geneva: WHO, 1991: WHO.ARI.91.20 [online]. Available from URL: http://www.who.int/child- adolescent-health/New_Publications/ CHILD_HEALTH/WHO.ARI.91.20.pdf [Accessed 2005 Apr 22]
22. Shann F. Etiology of severe pneumonia in children in developing countries. Pediatr Infect Dis 1986; 5: 247-52
23. Forgie IM, O'Neill KP, Lloyd-Evans N, et al. Etiology of acute lower respiratory tract infections in Gambian children. II: acute lower respiratory tract infection in children ages one to nine years presenting at the hospital. Pediatr Infect Dis J 1991; 10: 42-7
24. Falade AG, Mulholland EK, Adegbola RA, et al. Bacterial isolates from blood and lung aspirate cultures in Gambian children with lobar pneumonia. Ann Trop Paediatr 1997; 17: 315-9
25. Vuori-Holopainen E, Salo E, Saxen H, et al. Etiological diagnosis of childhood pneumonia by use of transthoracic needle aspiration and modern microbiological methods. Clin Infect Dis 2002; 34: 583-90. Epub 2002 Jan 16
26. Jokinen C, Heiskanen L, Juvonen H, et al. Incidence of community acquired pneumonia in the population of four municipalities in eastern Finland. Am J Epidemiol 1993; 137: 977-88
27. Murphy TF, Henderson FW, Clyde Jr WA, et al. Pneumonia: an eleven-year study in a pediatric practice. Am J Epidemiol 1981; 113: 12-21
28. World Health Organization. Acute respiratory infections in children: case management in small hospitals in developing countries: a manual for doctors and other senior health workers. programme for the control of acute respiratory infections. WHO/ARI/90.5. Geneva: World Health Organization, 1990
29. Leventhal JM. Clinical predictors of pneumonia as a guide to ordering chest roentgenograms. Clin Pediatr 1982; 21: 730-4
30. Shann F, Hart K, Thomas D. Acute lower respiratory tract infections in children: possible criteria for selection of patients for antibiotic therapy and hospital admission. Bull World Health Organ 1984; 62: 749-53
31. Redd SC, Vreuls R, Metsing M, et al. Clinical signs of pneumonia in children attending a hospital outpatient department in Lesotho. Bull World Health Organ 1994; 72: 113-8
32. Campbell H, Byass P, Greenwood BM. Simple signs for diagnosis of acute respiratory infections. Lancet 1988; II: 742-3
33. Cherian T, John TJ, Simoes E, et al. Evaluation of simple clinical signs for the diagnosis of acute lower respiratory tract infection. Lancet 1988; II: 125-8
34. Berman S, Simoes EA, Lanata C. Respiratory rate and pneumonia in infancy. Arch Dis Child 1991; 66: 81-4
35. Mulholland EK, Simoes EA, Costales MO, et al. Standardized diagnosis of pneumonia in developing countries. Pediatr Infect Dis J 1992; 11: 77-81
36. Bettenay FA, de Campo JF, McCrossin DB. Differentiating bacterial from viral pneumonias in children. Pediatr Radiol 1988; 18: 453-4
37. Courtoy I, Lande AE, Turner RB. Accuracy of radiographic differentiation of bacterial from nonbacterial pneumonia. Clin Pediatr 1989; 28: 261-4
38. Juven T, Mertsola J, Waris M, et al. Etiology of community-acquired pneumonia in 254 hospitalized children. Pediatr In fect Dis J 2000 Apr; 19 (4): 293-8
39. Korppi M, Leinonen M, Koskela M, et al. Bacterial coinfection in children hospitalized with respiratory syncytial virus infec-tions. Pediatr Infect Dis J 1989 Oct; 8 (10): 687-92
40. Hietala J, Uhari M, Tuokko H, et al. Mixed bacterial and viral infections are common in children. Pediatr Infect Dis J 1989; 8: 683-6
41. Korppi M. Mixed microbial aetiology of community-acquired pneumonia in children. APMIS 2002; 110: 515-22
42. Klein JO. Bacterial pneumonias. In: Feigin RD, Cherry JD, editors. Textbook of pediatric infectious diseases. 4th ed. Phil-adelphia (PA): WB Saunders, 1998: 83
43. Prober CG. Pneumonia. In: Behrman RE, Kliegman RM, Jenson HB, editors. Nelson textbook of pediatrics. 16th ed. Philadel-phia (PA): WB Saunders, 2000: 761-5
44. American Academy of Pediatrics 2000 red book: report of the committee on infectious diseases. 25th ed. Elk Grove Village (IL): American Academy of Pediatrics, 2000: 262-65, 452-57
45. Pichichero ME. Short course antibiotic therapy for respiratory infections: a review of the evidence. Pediatr Infect Dis J 2000 Sep; 19 (9): 929-37
46. Jadavji T, Law B, Lebel MH, et al. A practical guide for the diagnosis and treatment of pediatric pneumonia. CMAJ 1997; 156: S703-11
47. American Academy of Pediatrics. Therapy for children with invasive pneumococcal infections: American Academy of Pediatrics Committee on Infectious Diseases. Pediatrics 1997; 99: 289-99
48. McCracken Jr GH. Diagnosis and management of pneumonia in children. Pediatr Infect Dis J 2000; 19: 924-8
49. British Thoracic Society. Guidelines for the management of community acquired pneumonia in children. Thorax 2002; 57: i1-i24
50. World Health Organization. The management of acute respiratory infections in children: practical guidelines for outpatient care. Geneva: World Health Organization, 1995
51. Sazawal S, Black RE. Effect of pneumonia case management on mortality in neonates, infants, and preschool children: a meta-analysis of community-based trials. Lancet Infect Dis 2003; 3: 547-56
52. Berman S. Epidemiology of acute respiratory infections. Rev Infect Dis 1991; 13 Suppl. 6: S454-62
53. Pechere JC. Parameters important in short antibiotic courses. J Int Med Res 2000; 28 Suppl. 1: 3A-12A
54. Dagan R, Leibovitz E. Bacterial eradication in the treatment of otitis media. Lancet Infect Dis 2002; 2: 593-604
55. Wood MJ. Therapy: the clinician's view. J Antimicrob Chemother 1990; 25 Suppl. C: 99-106
56. Gold HS, Moellering Jr RC. Antimicrobial-drug resistance. N Engl J Med 1996; 335: 1445-53
57. Guillemot D, Carbon C, Balkau B, et al. Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae. JAMA 1998; 279: 365-70
58. Seppala H, Klaukka T, Vuopio-Varkila J, et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland: Finnish Study Group for Antimicrobial Resistance. N Engl J Med 1997; 337: 441-6
59. World Health Organization. WHO global strategy for contain-ment of antimicrobial resistance. WHO/CDS/CSR/DRS/2001.2. Geneva: WHO, 2001
60. Steinke D, Davey P. Association between antibiotic resistance and community prescribing: a critical review of bias and confounding in published studies. Clin Infect Dis 2001 Sep 15; 33 Suppl. 3: S193-205
61. Tenover FC. Development and spread of bacterial resistance to antimicrobial agents: an overview. Clin Infect Dis 2001 Sep 15; 33 Suppl. 3: S108-15
62. Schrag SJ, Pena C, Fernandez J, et al. Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage: a randomized trial. JAMA 2001; 286: 49-56
63. Standing Medical Advisory Committee, Sub-Group on Antimi-crobial Resistance. The path of least resistance. London: Department of Health, 1998
64. Kristinsson KG. Effect of antimicrobial use and other risk factors on antimicrobial resistance in pneumococci. Microb Drug Resist 1997; 3: 117-23
65. Campbell H. Acute respiratory infection: a global challenge. Arch Dis Child 1995; 73: 281-6
66. Adam D. Short-course antibiotic therapy for infections with a single causative pathogen. J Int Med Res 2000; 28 Suppl. 1: 13A-24A
67. Tulloch J. Integrated approach to child health in developing countries. Lancet 1999 Sep; 354 Suppl. II: SII16-20
68. Harris CM, Lloyd DC. Consider short courses of antibiotics [letter]. BMJ 1994; 308: 919
69. Al-Eidan FA, McElnay JC, Scott MG, et al. Sequential antimicrobial therapy: treatment of severe lower respiratory tract infections in children. J Antimicrob Chemother 1999; 44: 709-15
70. Bergman AB, Werner RJ. Failure of children to receive penicillin by mouth. N Engl J Med 1963; 268: 1334-8
71. Pechere JC. Patients' interviews and misuse of antibiotics. Clin Infect Dis 2001; 33 Suppl. 3: S170-3
72. Branthwaite A, Pechere JC. Pan-European survey of patients' attitudes to antibiotics and antibiotic use. J Int Med Res 1996; 24: 229-38
73. Roord JJ, Wolf BH, Gossens MM, et al. Prospective open randomized study comparing efficacies and safeties of a 3-day course of azithromycin and a 10-day course of erythromycin in children with community-acquired acute lower respiratory tract infections. Antimicrob Agents Chemother 1996; 40: 2765-8
74. Schaad U. Multicentre evaluation of azithromycin in comparison with co-amoxyclav for the treatment of acute otitis media in children. J Antimicrob Chemother 1993; 31 Suppl. E: 81-8
75. Gehanno P, Taillebe M, Denis P, et al. Short-course cefotaxime compared with five-day co-amoxyclav in acute otitis media in children. J Antimicrob Chemother 1990; 26 Suppl. A: 29-36
76. Gooch WM, Blair E, Puopolo A, et al. Effectiveness of five days of therapy with cefuroxime axetil suspension for treatment of acute otitis media. Pediatr Infect Dis J 1996; 15: 157-64
77. Khurana CM. A multicenter, randomized, open label comparison of azithromycin and amoxicillin/clavulanate in acute otitis media among children attending day care or school. Pediatr Infect Dis J 1996; 15 (9 Suppl.): S24-9
78. Hoberman A, Paradise JL, Burch DJ, et al. Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin) for the treatment of otitis media in children. Pediatr Infect Dis J 1997; 16: 463-70
79. Cohen R, Navel M, Grunberg J, et al. One dose ceftiaxone vs ten days of amoxicillin/clavulanate therapy for acute otitis media. Pediatr Infect Dis J 1999; 18: 403-9
80. Roos K, Larsson P. Efficacy of ceftibuten in 5 vs 10 days treatment of recurrent otitis media in children. Int J Pediatr Otorhinolaryngol 2000; 55: 109-15
81. Paradise JL. Managing otitis media: a time for change. Pediatrics 1995; 96 (4 Pt 1): 712-5
82. Dowell SF, Marcy SM, Phillips WR, et al. Principles of judicious use of antimicrobial agents for pediatric upper respiratory tract infections. Pediatrics 1998; 101: 163-5
83. Lambert HP. Don't keep taking the tablets? Lancet 1999; 354: 943-5
84. Sutton DR, Wicks ACB, Davidson L. One-day treatment for lobar pneumonia. Thorax 1970; 25: 241-4
85. Sibellas M. Treatment of lobar pneumonia in out-patients. J Trop Med Hyg 1966; 69: 94-6
86. Harris JA, Kolokathis A, Campbell M, et al. Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children. Pediatr Infect Dis J 1998; 17: 865-71
87. Wubbel L, Muniz L, Ahmed A, et al. Etiology and treatment of community-acquired pneumonia in ambulatory children. Pediatr Infect Dis J 1999; 18: 98-104
88. Kogan R, Martinez MA, Rubilar L, et al. Comparative random-ized trial of azithromycin versus erythromycin and amoxicillin for treatment of community-acquired pneumonia in children. Pediatr Pulmonol 2003; 35: 91-8
89. Ficnar B, Huzjak N, Oreskovic K, et al. Azithromycin: 3-day versus 5-day course in the treatment of respiratory tract infections in children. Croatian Azithromycin Study Group. J Chemother 1997; 9: 38-43
90. Langtry HD, Balfour JA. Azithromycin: a review of its use in paediatric infectious diseases. Drugs 1998; 56 (2): 273-97
91. Gordon EM, Blumer JL. Rationale for single and high dose treatment regimens with azithromycin. Pediatr Infect Dis J 2004; 23 (2 Suppl.): S102-7
92. Campbell H, Byass P, Forgie IM, et al. Trial of co-trimoxazole versus procaine penicillin with ampicillin in treatment of community-acquired pneumonia in young Gambian children. Lancet 1988; II: 1182-4
93. Keeley DJ, Nkrumah FK, Kapuyanyika C. Randomized trial of sulfamethoxazole + trimethoprim versus procaine penicillin for the outpatient treatment of childhood pneumonia in Zimbabwe. Bull World Health Organ 1990; 68: 185-92
94. Catchup Study Group. Clinical efficacy of co-trimoxazole versus amoxicillin twice daily for treatment of pneumonia: a randomised controlled clinical trial in Pakistan. Arch Dis Child 2002; 86: 113-8
95. Rasmussen ZA, Bari A, Qazi S, et al., for the Pakistan COMET (Cotrimoxazole Multicentre Efficacy Trial) Study Group. Randomised controlled trial of standard and double dose co-trimoxazole for treatment of childhood pneumonia in Pakistan. Bull World Health Organ 2005; 83: 10-9
96. Vuori-Holopainen E, Peltola H, Kallio MJ. Narrow- versus broad-spectrum parenteral anatimicrobials against common infections of childhood: a prospective and randomised comparison between penicillin and cefuroxime. SE-TU Study Group. Eur J Pediatr 2000; 159: 878-84
97. Peltola H, Vuori-Holopainen E, Kallio MJ. Successful shortening from seven to four days of parenteral beta-lactam treatment for common childhood infections: a prospective and randomized study. SE-TU Study Group. Int J Infect Dis 2001; 5: 3-8
98. Pakistan Multicentre Amoxicillin Short Course Therapy (MAS-COT) Pneumonia Study Group. Clinical efficacy of 3 days versus 5 days of oral amoxicillin for treatment of childhood pneumonia: a multicentre double-blind trial. Lancet 2002; 360: 835-41
99. Qazi S. Oral amoxicillin for childhood pneumonia. Lancet 2003; 361: 76-7
100. ISCAP Study Group. 3- versus 5-day treatment with amoxicillin for non-severe pneumonia in young children: a multi-centre randomized trial. BMJ 2004; 328: 791-7. Epub 2004 Mar 16
101. Kartasasmita C, Saha S, Short Course Cotrimoxazole Study Group. Three days vs five days oral cotrimoxazole therapy in non-severe pneumonia. In: Consultative Meeting to Review Evidence and Research Priorities in the Management of Acute Respiratory Infections (ARI). Geneva, World Health Organization, 2003 Sep 29-Oct 1: meeting report. Geneva: Department of Child and Adolescent Health and Development, World Health Organization, 2004: 3-4. Report no. WHO/FCH/CAH/ 04.2 [online]. Available from URL: http://www.who.int/child- adolescent-health/New_Publications/CHILD_HEALTH/ WHO_FCH_CAH_04.2.pdf [Accessed 2005 Apr 22]
102. World Health Organization. Report of consultative meeting to review evidence and research priorities in the management of acute respiratory infections (ARI). Geneva: 2003 Sep 29-Oct 1. WHO/FCH/CAH/04.2 [online]. Available from URL: http:// www.who.int/child-adolescent-health/ New_Publications/ CHILD_HEALTH/WHO_FCH_CAH_04.2.pdf [Accessed 2005 Apr 22]